3 reports of this reaction
13.0% of all CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR reports
#1 most reported adverse reaction
DRUG ABUSE is the #1 most commonly reported adverse reaction for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, manufactured by ARMY AND AIR FORCE EXCHANGE SERVICE. There are 3 FDA adverse event reports linking CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR to DRUG ABUSE. This represents approximately 13.0% of all 23 adverse event reports for this drug.
Patients taking CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR who experience drug abuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG ABUSE is a frequently reported adverse event for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, accounting for a significant proportion of all reports.
In addition to drug abuse, the following adverse reactions have been reported for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR:
The following drugs have also been linked to drug abuse in FDA adverse event reports:
DRUG ABUSE has been reported as an adverse event in 3 FDA reports for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG ABUSE accounts for approximately 13.0% of all adverse event reports for CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, making it one of the most commonly reported side effect.
If you experience drug abuse while taking CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.